NCT00177684View on ClinicalTrials.gov

Pharmacokinetic Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet ®)

PHASE3CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

September 30, 2005

Conditions
Lung TransplantationFungal Infections
Interventions
DRUG

Amphotericin B

Trial Locations (1)

15213

University of Pittsburgh Medical Center, Pittsburgh

Sponsors
All Listed Sponsors
collaborator

Enzon Pharmaceuticals, Inc.

INDUSTRY

lead

University of Pittsburgh

OTHER